Bellemin Jean-Marc
Iovance Biotherapeutics, Inc. · Chief Financial Officer
Bellemin Jean-Marc is listed in public filings as officer: Chief Financial Officer. This Bellemin Jean-Marc insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Iovance Biotherapeutics, Inc. (IOVA). Investors use Bellemin Jean-Marc's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --61.5k shares | Grant / ExerciseJun 2, 2025 | Disclosure amount unavailable8.8k shares | -- | -- | |
| $107k60.5k shares | Grant / ExerciseJun 2, 2025 | $7.9K4.5k shares | $1.76 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --93.8k shares | Grant / ExerciseMar 5, 2025 | Disclosure amount unavailable93.8k shares | -- | -- | |
| --70.3k shares | Grant / ExerciseMar 3, 2025 | Disclosure amount unavailable58.6k shares | -- | -- | |
| $227k56.2k shares | Grant / ExerciseMar 3, 2025 | $128.2K31.7k shares | $4.04 | -- | |
| --23.4k shares | Grant / ExerciseSep 3, 2024 | Disclosure amount unavailable23.4k shares | -- | -- | |
| $318k29.3k shares | Grant / ExerciseSep 3, 2024 | $129.0K11.9k shares | $10.85 | -- |